Traded Jun 15 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded May 19, 2026 · Filed May 19, 2026
Exponent's Group Vice President sold $98K of Exponent shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$98,062
Shares × reported transaction price
19 days after results of Apr 30, 2026, 72 days before results of Jul 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.0% | +1.2% | −3.2% |
| 30 days | −4.0% | +0.4% | −4.5% |
| 90 days | +15.9% | +3.5% | +12.4% |
Past results only. Not a forecast.
Traded Jun 15 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Catherine Corrigan (President & CEO) sold ~$133K of Exponent, Inc.
Automatic saleTraded Jun 15 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.